Takeda Shareholder `Skeptical' About Shire Takeover, Sunday Times Says

(Bloomberg) -- One of the top 10 shareholders in Japanese drugmaker Takeda Pharmaceutical Co. is “skeptical” on the value that will be created from the group’s $62 billion takeover of rare disease ...